Join us for an insightful conversation with Karim Asaad, Managing Director for Emerging Markets at Revvity, a global leader in life sciences and diagnostics.

Karim shares key insights on:

• 🔷 Revvity’s transition from PerkinElmer and its vision for the future
• 🔷 The importance of newborn screening in reducing healthcare costs
• 🔷 The role of genomics in advancing personalized medicine
• 🔷 Strategic partnerships to enhance healthcare across emerging markets

Whether you’re in healthcare, life sciences, or policy-making, this conversation offers valuable perspectives on innovation and accessibility in diagnostics.

#mededgemea #Revity #NewbornScreening #LifeSciences #Genomics #HealthcareInnovation #MidLabs2025 Medlab Series – Medical Laboratory Industry Forum

Also Watch : Transforming Healthcare with Wellness Pharmacy | Dr. Kathy Campbell’s Insights | Duphat 2025